SCHEMBL400907

SCHEMBL400907

CC(C)(C)SOSC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13262899 0.71
SCHEMBL5396635 0.70
SCHEMBL4046097 0.67
SCHEMBL18567572 0.67 TSHR (0.31)
SCHEMBL13052256 0.67
SCHEMBL20939947 0.65
SCHEMBL152843 0.53
SCHEMBL94585 0.53
SCHEMBL40671 0.53
SCHEMBL18335409 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130224211-A1 GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-08-29 US claimed
US-20090093642-A1 PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE PHARMATECH INTERNATIONAL, INC. 2009-04-09 US claimed
WO-2009045413-A1 PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE PHARMATECH INTERNATIONAL, INC. (US) 2009-04-09 WO claimed
US-12611462-B2 Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof CITY OF HOPE (US) 2026-04-28 US disclosed
US-20260028482-A1 Substitution at the Central Position of Heptamethine Dyes By Aryllithium Addition for Improved Fluorophores UNIV ARKANSAS (US) 2026-01-29 US disclosed
US-20240245647-A1 ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2024-07-25 US disclosed
US-11891448-B2 Glycated CD59 peptides, their preparation, and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-02-06 US disclosed
WO-2022266394-A9 NOVEL ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2024-01-04 WO disclosed
US-11708384-B2 Systems and methods for mechanosynthesis CBN NANO TECHNOLOGIES INC. (CA) 2023-07-25 US disclosed
EP-3514822-B1 METHOD FOR MANUFACTURING FIELD EFFECT TRANSISTOR AND METHOD FOR MANUFACTURING WIRELESS COMMUNICATION DEVICE TORAY INDUSTRIES (JP) 2023-04-26 EP disclosed
US-11592463-B2 Systems and methods for mechanosynthesis CBN NANO TECHNOLOGIES INC. (CA) 2023-02-28 US disclosed
WO-1995004277-A1 A METHOD FOR PREPARING AND SELECTING PHARMACEUTICALLY USEFUL NON-PEPTIDE COMPOUNDS FROM A STRUCTURALLY DIVERSE UNIVERSAL LIBRARY SPHINX PHARMACEUTICALS CORPORATION (US) 1995-02-09 WO disclosed
EP-0637309-A1 METAL COATINGS BIOCOMPATIBLES LIMITED (GB) 1995-02-08 EP disclosed
WO-1993025003-A9 SUB-NANOSCALE ELECTRONIC SYSTEMS, DEVICES AND PROCESSES 1994-05-26 WO disclosed
WO-1993025003-A1 SUB-NANOSCALE ELECTRONIC SYSTEMS, DEVICES AND PROCESSES YALE UNIVERSITY (US) 1993-12-09 WO disclosed
WO-1993022320-A1 METAL COATINGS BIOCOMPATIBLES LIMITED (GB) 1993-11-11 WO disclosed
US-4876296-A SHEET MOLDING; UNSATURATED POLYESTER CORE MIXTURE WITH THERMOPLASTIC RESIN SHELL OLIN CORPORATION (US) 1989-10-24 US disclosed
EP-0132101-A1 2-Heterocycloalkylthiopenem derivatives PFIZER INC. (US) 1985-01-23 EP disclosed
US-4277394-A ANALGESICS, ANTIDIARRHEA, TREATMENT OF MENTAL DISEASE TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1981-07-07 US disclosed
EP-0005248-A2 Tetrapeptidehydrazide derivatives and process for their preparation Takeda Chemical Industries, Ltd. (JP) 1979-11-14 EP disclosed